Qizhen Shi/X
Aug 24, 2025, 08:35
Qizhen Shi: Immune Regulation in Hemophilia—Insights from TFH/TFR
Qizhen Shi, Professor at the Medical College of Wisconsin and Senior Investigator at Versiti Blood Research Institute, posted on X:
”Our new paper is out in Blood!
“The TFH/TFR pathway in FVIII immune responses in mice”
1) TFR cells have a dual role in regulating anti-FVIII responses
2) TFH/TFR axis is key to inhibitor development in hemophilia A .”
Read the full article here.
Title: The T follicular helper/T follicular helper regulatory pathway in FVIII immune responses in mice
Authors: Weiqing Jing, Jocelyn A. Schroeder, Saurabh Kumar, Juan Chen, Yuanhua Cai, Lynn M. Malec, Alexander L. Dent, Weiguo Cui, Qizhen Shi
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids